New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Cellectar Biosciences, Inc. (CLRB) vs VistaGen Therapeutics, Inc. (VTGN)
- Cellectar Biosciences, Inc. CLRB 0.80 −9.09%
- VistaGen Therapeutics, Inc. VTGN 0.16 −15.79%
Cellectar Biosciences, Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and VistaGen Therapeutics, Inc. are of similar size ($8.9M and $8.6M). Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −2,475.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cellectar Biosciences, Inc. leads on 8 and VistaGen Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | CLRB | VTGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | 0.00% | (2,543.22%) | 0.00% |
| Net margin | 0.00% | (2,475.56%) | 0.00% |
| Free cash flow margin | 0.00% | (2,549.39%) | 0.00% |
| Return on equity | (172.99%) | (144.95%) | (51.58%) |
| Return on assets | (116.54%) | (112.97%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack